Biomics Biopharma (ASX:BBM) Total Liabilities: A$0.00 Mil (As of . 20)


What is Biomics Biopharma Total Liabilities?

Biomics Biopharma ASX:BBM Total Liabilities is A$0.00 Mil as of . 20.

Biomics Biopharma's Total Liabilities for the quarter that ended in . 20 was A$0.00 Mil.


Biomics Biopharma Total Liabilities Historical Data

* Premium members only.

The historical data trend for Biomics Biopharma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biomics Biopharma Total Liabilities Chart

Biomics Biopharma Annual Data
Trend
Total Liabilities

Biomics Biopharma Semi-Annual Data
Total Liabilities

Biomics Biopharma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Biomics Biopharma's Total Liabilities for the fiscal year that ended in . 20 is calculated as

Total Liabilities=Total Assets (A: . 20 )-Total Equity (A: . 20 )
=N/A-N/A
=N/A

Biomics Biopharma's Total Liabilities for the quarter that ended in . 20 is calculated as

Total Liabilities=Total Assets (Q: . 20 )-Total Equity (Q: . 20 )
=N/A-N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of A$0.00 Mil mean?
Biomics Biopharma (ASX:BBM) has a Total Liabilities of A$0.00 Mil as of . 20. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Biomics Biopharma and its competitors.
Is Biomics Biopharma's Total Liabilities too high?
Biomics Biopharma's current Total Liabilities is A$0.00 Mil.
How does Biomics Biopharma's Total Liabilities compare to competitors?
Biomics Biopharma's Total Liabilities of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Biomics Biopharma and its competitors. Biomics Biopharma's current Total Liabilities is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biomics Biopharma stock overvalued right now?
Biomics Biopharma (ASX:BBM) has a current Total Liabilities of A$0.00 Mil. The current Total Liabilities is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Biomics Biopharma (ASX:BBM), the current Total Liabilities is A$0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biomics Biopharma Business Description

Address 1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.